Literature DB >> 9867539

Iron chelation with oral deferiprone in patients with thalassemia.

M Stella, G Pinzello, A Maggio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9867539

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

Review 1.  Friedreich ataxia-update on pathogenesis and possible therapies.

Authors:  Max Voncken; Panos Ioannou; Martin B Delatycki
Journal:  Neurogenetics       Date:  2003-12-19       Impact factor: 2.660

2.  Serum carnitine levels in patients with homozygous beta thalassemia: a possible new role for carnitine?

Authors:  Vasileios Tsagris; Georgia Liapi-Adamidou
Journal:  Eur J Pediatr       Date:  2004-11-30       Impact factor: 3.183

Review 3.  Deferiprone: a review of its clinical potential in iron overload in beta-thalassaemia major and other transfusion-dependent diseases.

Authors:  J A Barman Balfour; R H Foster
Journal:  Drugs       Date:  1999-09       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.